Another strong performance was achieved by the Asia/Pacific (APAC) region. At €227.2m, revenue was significantly higher than the prior-year figure of €186.7m – an increase of 21.7 percent (adjusted for currency effects: 18.4 percent). A large part of this growth is again attributable to the Chinese market, as well as Southeast Asia and India.
Revenue in the EMEA region declined slightly by 1.3 percent in the first six months of 2016/17 (adjusted for currency effects: -0.6 percent) – however, compared with a weak start of the year, the business development was more stable in the second quarter of 2016/17. Revenue of €175.4m (prior year: €177.7m) was recorded. There was a downturn in business particularly in the United Kingdom, Southern Europe and Middle East.
Revenue in the Americas region further increased by 4.8 percent (adjusted for currency effects: 2.7 percent) to revenue of €184.9m (prior year: €176.4m).
Earnings per share (EPS) increased significantly year-on-year, to €0.76 (prior year: €0.59). The increase in operating profit contributed to this. The revenue target of Carl Zeiss Meditec AG lies within the range of €1,150m to €1,200m for fiscal year 2016/17. The EBIT margin is expected to be within the range also forecast for the medium term, of 13 percent to 15 percent.